Posted by Michael Wonder on 07 Jul 2023
Broader Medicare coverage of Leqembi available following FDA traditional approval
6 July 2023 - Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (lecanemab) following the FDA's move to grant traditional approval to the drug that treats individuals with Alzheimer’s disease.
The Centers for Medicare & Medicaid Services had previously announced this would be the case and released more details on coverage today.
